Texas Heart Institute Journal: Volume 48, Issue 3

We are excited to share a new issue of the Texas Heart Institute Journal, now available online.

The Texas Heart Institute Journal is a peer-reviewed journal published bimonthly by the Texas Heart Institute as part of its medical education program and also as a continuous publication (NEW in 2021!). The purpose of the Journal is to educate, with emphasis on the dissemination of information to physicians in practice. For more information, visit the THI Journal pages on our website.

Our medical and scientific experts bring a wealth of knowledge and experience that make the THI Journal possible. Members of this group deserve our continuing gratitude and recognition.

Volume 48 Issue 3 of the Journal features the following articles:


Venovenous Extracorporeal Membrane Oxygenation to Facilitate Removal of Endobronchial Tumors
Bryan Miles, BA; Lucian A. Durham, MD, PhD; Jonathan Kurman, MD; Lyle D. Joyce, MD, PhD; David W. Johnstone, MD; David Joyce, MD; Paul J. Pearson, MD, PhD

Use of Intracardiac Echocardiography to Evaluate Continuous-Flow Left Ventricular Assist Device Function in a Man With Obesity
Charlene L. Rohm, MD; Brian Howard, MD; Baqir Lakhani, DO; Marian Wilim, NP; Rachel W. Holden, RN; David Snipelisky, MD

Managing Thrombosis and Hemorrhage in a Man with Myocardial Infarction and Traumatic Hemopericardium with Cardiac Tamponade
Aaron L. Bush, MD; Joseph Allencherril, MD; Mahboob Alam, MD

Percutaneous Hydrogel Coil Embolization of Aneurysms and Coronary Artery Fistulae in Congenital Heart Disease
Steven J. Healan, MD, MSCI; George Nicholson, MD; Thomas Doyle, MD; Dana Janssen, MD

Delayed Treatment of Acute Myocardial Infarction With Ventricular Septal Rupture Due to Patient Fear During the COVID-19 Pandemic
Minar Chhetry, MD; Reema Bhatt, MD; Nathan H. Tehrani, MD; Dimitrios V. Avgerinos, MD; Charles A. Mack, MD; Samuel J. Lang, MD; Xuming Dai, MD, PhD



Cardiovascular Outcomes in Patients With Mitochondrial Disease in the United States: A Propensity Score Analysis
Tran Nguyen, MD; Talal Alzahrani, MD, MPH; Joseph Krepp, MD; Gurusher Panjrath, MD

Sustained Use of the Impella 5.0 Heart Pump Enables Bridge to Clinical Decisions in 34 Patients
Daniel W. Nelson, MD; Sakthi Sundararajan, MD; Evan Klein, MD; Lyle D. Joyce, MD, PhD; Lucian A. Durham, MD, PhD; David L. Joyce, MD; Asim A. Mohammed, MD



A Review of the Cardiac and Cardiovascular Effects of COVID-19 in Adults and Children
Bibhuti B. Das, MD; S. Kristen Sexon Tejtel, MD; Shriprasad Deshpande, MD; Lara S. Shekerdemian, MD, MHA

Pathophysiology of Takotsubo Cardiomyopathy: Reopened Debate
Paolo Angelini, MD; Carlo Uribe, MD; Jonathan M. Tobis, MD

About the Texas Heart Institute Journal

The Texas Heart Institute Journal is published by Texas Heart Institute, Houston, Texas (ISSN 1526-6702). The Journal was printed under the name of Cardiovascular Diseases from 1974 through 1981 (ISSN 0093-3546). The name was changed to Texas Heart Institute Journal in 1982, and the Journal was printed through 2013 (ISSN 0730-2347). It is indexed by Index Medicus/MEDLINE and by other indexing and abstracting services worldwide.

The statements and opinions expressed in the Texas Heart Institute Journal are those of their authors and are not necessarily those of the Texas Heart Institute Journal, the Texas Heart Institute, the Texas Heart Institute Foundation, or affiliated institutions.